Vertex Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.9% | +15.9% | +22.5% | +76.1% | +33.2% | +41.3% | +14.3% | +35.1% | +25.2% | -0.9% | +16.0% | |
| – | -12.4% | +30.0% | +41.0% | +49.1% | +30.3% | +68.6% | +17.5% | +38.4% | +6.9% | -32.2% | +16.7% | |
| – | +14.3% | +65.6% | +40.7% | +59.1% | +17.3% | +92.6% | +13.5% | +54.6% | -1.3% | -55.9% | +11.3% | |
| – | -24.8% | +37.6% | +45.6% | +51.7% | +20.2% | +74.9% | +13.0% | +43.2% | +4.1% | -45.5% | +8.1% | |
| – | +97.3% | +13.2% | +39.9% | +45.6% | +54.6% | +39.8% | +28.4% | +26.9% | +8.4% | +2.9% | +27.6% | |
| – | +81.8% | +38.4% | +44.1% | +11.2% | +34.7% | +67.6% | +25.8% | +30.4% | +60.4% | +63.2% | +39.9% | |
| – | -2.5% | +0.1% | +13.0% | +2.9% | +2.6% | +15.0% | +14.1% | +33.1% | – | – | – | |
| – | +26.2% | +0.0% | +0.0% | +0.0% | +1,889.0% | +0.0% | +0.0% | +8.6% | +0.0% | +0.0% | +0.0% | |
| – | +880.5% | +0.0% | -89.8% | +73.7% | +693.9% | +0.0% | +0.0% | +50.9% | +39.1% | -1.7% | -48.6% | |
| – | +13.4% | +10.8% | -3.3% | +20.4% | +23.3% | +37.2% | +8.7% | +27.2% | +21.5% | +18.9% | +22.1% | |
| – | +37.5% | -98.4% | +10,049.1% | -11.4% | +86.6% | +40.7% | +14.1% | +28.0% | +29.4% | +0.5% | +8.3% | |
| – | +171.8% | +267.1% | -92.9% | -56.4% | +295.2% | +9.3% | +89.2% | +11.5% | -6.4% | +10.3% | -10.3% | |
| – | +5.3% | -18.0% | +20.4% | +50.0% | -21.1% | +77.0% | +25.7% | +55.8% | +20.1% | +13.2% | +11.8% | |
| – | -7.6% | -30.2% | +15.8% | -0.3% | – | – | – | – | – | – | – | |
| – | +1.6% | +22.5% | +52.6% | +117.2% | +37.2% | +42.8% | +16.3% | +37.7% | +26.4% | -6.7% | +13.7% | |
| – | – | – | – | – | – | – | +272.8% | +103.8% | +55.5% | -5.3% | +41.2% | |
| – | +2.6% | +1.4% | +3.5% | +2.4% | +0.6% | +1.0% | -1.3% | -0.3% | +0.5% | -1.0% | +0.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.